G-Estimation and Artificial Censoring: Problems, Challenges, and Applications

Biometrics

Volumn 68, Issue 1, 2012, Pages 275-286

  Joffe, Marshall M ^a   Yang, Wei Peter ^a   Feldman, Harold ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Causal inference; End stage renal disease; G estimation; Structural nested models

Indexed keywords

CAUSAL INFERENCES; END-STAGE RENAL DISEASE; ESTIMATING FUNCTIONS; FAILURE TIME; G-ESTIMATION; IMPROVE PERFORMANCE; OPTIMISATIONS; OPTIMIZATION PROCEDURES; STRUCTURAL NESTED MODEL; VARIANCE ESTIMATION;

BIOMETRICS;

DATA SET; ESTIMATION METHOD; NUMERICAL MODEL; OBSERVATIONAL METHOD; OPTIMIZATION;

EID: 84858865220     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/j.1541-0420.2011.01656.x     Document Type: Article

References (21)

1. Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., and Goodkin, D. A. (1998). The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. New England Journal of Medicine 339, 584-590.
2. Cotter, D. J., Stefanik, K., Zhang, Y., Thamer, M., Scharfstein, D., and Kaufman, J. (2004). Hematocrit was not validated as a surrogate end point for survival among epoetin-treated hemodialysis patients. Journal of Clinical Epidemiology 57, 1086-1095.
3. Drueke, T. B., Locatelli, F., Clyne, N., Eckardt, K.-U., Macdougall, I. C., Tsakiris, D., Burger, H.-U., and Scherhag, A. (2006), "Normalization of hemoglobin level in patients with chronic kidney disease and anemia, " New England Journal of Medicine 355, 2071-2084.
4. Greenland, S., and Neutra, R. (1980). Control of confounding in the assessment of medical technology. International Journal of Epidemiology 9, 361-367.
5. Hernan, M. A., Alonso, A., Logan, R., Grodstein, F., Michels, K. B., Willett, W. C., Manson, J. E., and Robins, J. M. (2008). Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology 19, 766-779.
6. Joffe, M. M. (2001). Administrative and artificial censoring in censored regression models. Statistics in Medicine 20, 2287-2304.
7. Joffe, M. M., Yang, W. P., and Feldman, H. I. (2010). Selective ignorability assumptions in causal inference. International Journal of Biostatistics 6, article 11.
8. Kullback, S. and Leibler, R. A. (1951). On information and sufficiency. Annals of Mathematical Statistics 22, 79-86.
9. Miettinen, O. S. (1983). The need for randomization in the study of intended effects. Statistics in Medicine 2, 267-271.
10. Nelder, J. A. and Mead, R. (1965). A simplex method for function minimization. Computer Journal 7, 308-313.
11. Neugebauer, R., van der Laan, M. J., Joffe, M. M., and Tager, I. B. (2007). Causal inference in longitudinal studies with history-restricted marginal structural models. Electronic Journal of Statistics 1, 119-154.
12. Pfeffer, M. A., Burdmann, E. A., Chen, C. Y., Cooper, M. E., de, Z. D., Eckardt, K. U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., Lewis, E. F., McGill, J. B., McMurray, J. J., Parfrey, P., Parving, H. H., Remuzzi, G., Singh, A. K., Solomon, S. D., and Toto, R. (2009). A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. New England Journal of Medicine 361, 2019-2032.
13. Robins, J. (1986). A new approach to causal inference in mortality studies with a sustained exposure period-application to control of the healthy worker survivor effect. Mathematical Modelling 7, 1393-1512.
14. Robins, J. M. (1989). The analysis of randomized and non-randomized AIDS treatment trials using a new approach to causal inference in longitudinal studies. In Health Service Research Methodology: A Focus on AIDS, L. A. Sechrest (ed). NCHSR, U.S. Public Health Service.
15. Robins, J. (1992). Estimation of the time-dependent accelerated failure time model in the presence of confounding factors. Biometrika 79, 321-334.
16. Robins, J. M., Blevins, D., Ritter, G., and Wulfsohn, M. (1992). G-estimation of the effect of prophylaxis therapy for pneumocystic carinii pneumonia on the survival of AIDS patients. Epidemiology 3, 319-336.
17. Robins, J. M., Hernan, M. A., and Brumback, B. (2000). Marginal structural models and causal inference in epidemiology. Epidemiology 11, 550-560.
18. Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., and Reddan, D. (2006). Correction of anemia with epoetin alfa in chronic kidney disease. New England Journal of Medicine 355, 2085-2098.
19. Tan, Z. (2010). Bounded, efficient, and doubly robust estimation with inverse weighting. Biometrika 97, 661-682.
20. van der Laan, M. J., Petersen, M. L., and Joffe, M. M. (2005). History-adjusted marginal structural models and statically-optimal dynamic treatment regimens. International Journal of Biostatistics 1, article 4.
21. White, H. (1982). Maximum likelihood estimation of misspecified models. Econometrica, 50, 1-25.